HKND:NYE-Humankind Benefit Corporation - Humankind US Stock ETF (USD)

ETF | Others |

Last Closing

USD 31.6278

Change

+0.79 (+2.56)%

Market Cap

USD 0.14B

Volume

150.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-12 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.04 (+0.23%)

USD 65.72B
SGOV iShares® 0-3 Month Treasury B..

+0.02 (+0.02%)

USD 46.95B
JEPI JPMorgan Equity Premium Income..

-0.15 (-0.27%)

USD 39.24B
JPST JPMorgan Ultra-Short Income ET..

-0.02 (-0.04%)

USD 30.70B
DFAC Dimensional U.S. Core Equity 2..

+0.20 (+0.58%)

USD 29.60B
DTB DTE Energy Company 2020 Series

-0.06 (-0.34%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

-0.02 (-0.04%)

USD 21.14B
GBTC Grayscale Bitcoin Trust (BTC)

+2.40 (+2.99%)

USD 16.17B
AVUV Avantis® U.S. Small Cap Value..

+0.88 (+0.98%)

USD 14.82B
CGDV Capital Group Dividend Value E..

+0.13 (+0.36%)

USD 14.38B

ETFs Containing HKND

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.63% 43% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.63% 42% F 46% F
Trailing 12 Months  
Capital Gain 1.42% 43% F 49% F
Dividend Return 0.93% 26% F 19% F
Total Return 2.34% 29% F 39% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.83% 61% D- 51% F
Dividend Return 4.76% 60% D- 46% F
Total Return 0.94% 44% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 8.41% 57% F 82% B
Risk Adjusted Return 56.68% 61% D- 71% C-
Market Capitalization 0.14B 64% D 31% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.